๐จThe first ImmunoT Microcourse is happening on April 6!! Join us for an Introduction to Immunotherapy and hear from and engage with leading experts Brad Nelson @BCCancer and @mklevings on this important topic๐๐๐
The title of your paper is your shop front.
Here are 10 rules to write a compelling title for your scientific article.
A thread. ๐งต
#AcademicChatter@TheStrugglingS4#Postdoc
Are you an undergraduate student in ๐ฆ๐บ๐ง๐ท๐จ๐ฑ๐จ๐ณ๐จ๐ด๐ซ๐ท๐ฉ๐ช๐ญ๐ฐ๐ฎ๐ณ๐ฒ๐ฝ๐ต๐ฐ๐ฐ๐ท๐น๐ผ๐น๐ณ๐บ๐ฆ๐ฌ๐ง๐บ๐ธ and interested in a paid @MitacsCanada internship in my group @UBCChem in the summer of 2023? We have projects on #icenucleation and on #biogeochemistry. Apply by Sept 22 https://t.co/xEzt56Dt6f
Grateful to have had the opportunity to be a part of #bioorganicchemistry Gordon Research Conference (GRC) and the seminar (GRS). Fantastic group of scientists spanning from academia to the industries. Iโd love to remain as a part of and contribute to this outstanding community!
Grateful to have finally gotten to attend (and organize) the #bioorganicchemistryGRS with my cochair and friend @prat_i_k. Amazing group of scientists, fantastic talks and posters, and a wild game of volleyball. Thanks to all who came!
Reviewing ways of enabling university spin-offs to rapidly respond to global crises. UBC's nanomedicine spinoff company AbCellera Biologics Inc. sets an example.
https://t.co/7sfb77wleR
ETX0462 potentially represents the first new antibiotic class in 35 years to treat MDR Gram-negative infections.
The key to their success: optimizing permeation alongside target binding potency during antibiotic lead optimization.
https://t.co/8lBV9uQunz
Fantastic illustration by Mark Belan showing how COVID-19 antiviral pills and vaccines work at the cellular level https://t.co/LlSjexU3uy
#science#storytelling#Illustrations
Are you an undergraduate student interested in research experience in Canada? Are you also from Australia,Brazil,China,Colombia,France,Germany,Hong Kong,India,Mexico,Pakistan,Taiwan,Tunisia,Ukraine, UK,USA? Then apply for the Globalink Research Internship: https://t.co/eAQJeYtHPc
It's true! Todayโs success with #mRNA vaccines against #COVID19 comes from decades of research, including that of Dr. Pieter Cullis!
Learn more about the long road to these vaccines: https://t.co/tOnS50xBFl
All 22 N-glycan sites of SARS-CoV-2 Spike
37 remain highly conserved among the variants, opening an avenue for robust therapeutic intervention. The group now has "tools" that bind the virusโs protective layer and thereby block the virus from entering hosts' cells.
This is video of a SARS-Cov-2 spike protein under siege. Those little blobs buzzing around it are called lectins, and they could be the secret weapon in a new defence against COVID-19, new research from @UBCLifeSciences has found. 1/8
"Each of the elements in the covid-19 mRNA vaccine are highly intentional choices and it reflects the decades of fundamental research in RNA biology."
One unexpected legacy of this pandemic could be to accelerate the use of synthetic m-RNAs for cancer immunotherapy.
#mRNAvaccine
NEW #Outlook by Kellie Nance & @doc_jlmeier @NCIResearchCtr
summarizes the development & function of N1-methylpseudouridine, an RNA modification used to increase the safety and efficacy of messenger RNA vaccines targeting #COVID19: https://t.co/2j0KUwxxPs
Excited that @EmoryChem is having a faculty search this year! If you're on the job market in any area of chemistry, I hope you'll apply. And, no matter where you're applying, we want to help you successfully navigate the job search with our Faculty 411: https://t.co/RaIrxSL6NT
BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna โfor the development of a method for genome editing.โ